Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Default-risk tables, layered reinsurance, capital sufficiency tests—Enact Holdings’ SEC documents are packed with details that can make or break a mortgage-insurance thesis. If you have ever hunted for loss-reserve roll-forwards in a 300-page 10-K or tried to catch Enact Holdings insider trading Form 4 transactions before the market reacts, you know the challenge.
Stock Titan solves that challenge by pairing real-time EDGAR feeds with AI-powered summaries. Our platform surfaces exactly where each disclosure sits—whether it’s the claim-severity assumptions buried deep in the Enact Holdings annual report 10-K simplified, the delinquency rates in an Enact Holdings quarterly earnings report 10-Q filing, or a sudden capital-raising note in an Enact Holdings 8-K material events explained. Need context fast? Click the AI Synopsis button and get understanding Enact Holdings SEC documents with AI in plain English.
Practical use cases include:
- Instant alerts on Enact Holdings Form 4 insider transactions real-time to monitor executive stock moves.
- Side-by-side revenue and loss-ratio charts for quick Enact Holdings earnings report filing analysis.
- Pulling exact tables on CEO pay from the Enact Holdings proxy statement executive compensation section.
Every filing—10-K, 10-Q, 8-K, S-3, or DEF 14A—is indexed, timestamped, and annotated. No more wading through PDFs; our AI highlights what shifts in reserve methodology mean and flags trends across quarters. Stay ahead with complete coverage, crystal-clear explanations, and the confidence that you’re viewing Enact Holdings SEC filings explained simply.
Form 4 highlights: On 06/30/2025 Genworth Holdings, Inc., which remains the controlling stockholder of Enact Holdings, Inc. (ticker ACT), sold 691,152 Enact common shares to the issuer under an April 30, 2025 Share Repurchase Agreement. The transaction was coded “S” (sale) and priced at $35.4867 per share, a volume-weighted figure set by the agreement. Following the sale, Genworth still owns 120,243,555 shares, representing approximately 81 % of the outstanding stock, and reports the position as direct ownership.
The filing signals incremental execution of the parent-level liquidity strategy while modestly reducing Enact’s public float through an issuer buyback. No derivative securities were involved, and no change in board or executive relationships was disclosed.